The Spread of Multi Drug Resistant Infections Is Leading to an Increase in the Empirical Antibiotic Treatment Failure in Cirrhosis: A Prospective Survey

Epidemiology and outcomes of bloodstream infection in patients with cirrhosis

(2014) Michele Bartoletti et al.   JOURNAL OF HEPATOLOGY

P473 BACTERIAL INFECTIONS IN CIRRHOTIC PATIENTS: RISK FACTORS AND RATE OF FAILURE OF THE EMPIRICAL ANTIBIOTIC THERAPY

(2014) V. Di Gregorio et al.   JOURNAL OF HEPATOLOGY

Outcomes of Patients Hospitalized With Community-Acquired, Health Care–Associated, and Hospital-Acquired Pneumonia

(2013) Mario Venditti   ANNALS OF INTERNAL MEDICINE

Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end-stage liver disease (NACSELD) experience

(2012) Jasmohan S. Bajaj et al.   HEPATOLOGY

Bacterial resistance in cirrhotic patients: An emerging reality

(2012) Manuela Merli et al.   JOURNAL OF HEPATOLOGY

Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance

(2011) A.-P. Magiorakos et al.   CLINICAL MICROBIOLOGY AND INFECTION

Prevalence and risk factors of infections by multiresistant bacteria in cirrhosis: A prospective study

(2011) Javier Fernández et al.   HEPATOLOGY

Risk factors for resistance to ceftriaxone and its impact on mortality in community, healthcare and nosocomial spontaneous bacterial peritonitis

(2011) Xavier Ariza et al.   JOURNAL OF HEPATOLOGY

Cirrhotic Patients Are at Risk for Health Care–Associated Bacterial Infections

(2010) Manuela Merli et al.   Clinical Gastroenterology and Hepatology

EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis

(2010)   JOURNAL OF HEPATOLOGY

Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America

(2008) Helen W. Boucher et al.   CLINICAL INFECTIOUS DISEASES